Search results
Results from the WOW.Com Content Network
The Veterinary Drugs Directorate is the Canadian body responsible for putting all "veterinary products, such antimicrobials, growth promotion drugs and feed additives, through a rigorous approval process before they are licensed and sold for use" in Canada. [1]
The bulk of scheduled tests (avian influenza, Newcastle disease, bluetongue, pseudorabies, vesicular stomatitis and epizootic hemorrhagic disease) involve the use of validated test methods on traditional farm animal species and the qualification of these animals or their products for movement into, out of, or within Canada and in support of ...
There are no regulations on the imports of reptiles and amphibians, except for turtles and tortoises, which require an import permit from the Canadian Food Inspection Agency. Pet turtles and tortoises must have been in the owner’s possession in the country of origin and must accompany the owner into Canada. Permits for turtle and tortoise ...
In Canada, regulation of therapeutic goods is done by Health Canada and governed by the Food and Drug Act and associated regulations. In addition, the Controlled Drugs and Substances Act specifies additional regulatory requirements for controlled drugs and drug precursors.
Import notification is required for other commodities such as fish and meat. All commercial importers must have an import/export account with Canada Border Services Agency (CBSA) who refers food, animal and plant imports to the CFIA as required. Through various phytosanitary requirements, CBSA import controls often cause the CFIA to take notice.
Each of Canada's five veterinary schools has a student representative who sits on the CVMA's Student committee. [7] Veterinary students can attend an annual symposium in veterinary medicine including lectures and labs. [8] Students can also apply for CVMA scholarships. [9] [10]
The Export and Import Permits Act (French: Loi sur les licences d’exportation et d’importation, EIPA) is an Act passed by the Parliament of Canada originally in 1947 though it has had many amendments over the years. [1] It was assented originally by King George VI through his agent the Governor General of Canada. At present, contraventions ...
Patented Medicine Prices Review Board office in Ottawa. Bill C-22, which was passed in 1987, established a compulsory licensing system under which drug patent holders were required to allow competing drug manufacturers to import their patented drug in exchange for a very modest 4% royalty, which resulted in an increase in the market share of generic drugs.